# Project Health

## Audit Question, Depth, And Evidence Boundary

Can a small Acme team understand, prioritize, trace, review, accept, release,
operate, and learn from changes to Healthchecks as a core dependency? This was a
detailed delivery/process review at the 2026-08-19 cutoff. It used the pinned
`HC-CODE-001` source and history, public cutoff-bounded GitHub/Actions/release
records, the [evidence ledger](../../evidence/evidence-ledger.md) entries
E-056 through E-060, the
[GitHub/history packet](../../evidence/packets/github-history-and-hosted-ci.md),
and direct controls linked by the completed Code Quality, Revenue Risk,
Maintenance Cost, and Contributor/Vendor Value handoffs.

The review assesses process evidence, not product correctness, capability,
staffing, continuity, or live operation. No Acme work queue, release/change
policy, production record, incident review, named team, or vendor-change notice
was approved. Post-cutoff public API access was used only to validate records
effective on or before the cutoff.

## Coverage And Material Gaps

The review covered upstream intake and contribution rules, issue/commit/release
traceability, hosted CI and branch-enforcement limits, tag/changelog cadence,
Docker publication, documentation audiences, option-specific acceptance, Acme
release/change authority, work in flight, and learning. OI-022 owns the missing
Acme authority/change record; OI-023 owns work-to-learning traceability. OI-008
retains the technical promotion gate, OI-019 the operating calendar, and OI-017
the make stop condition.

The shared collector initially could not start its process environment. The
coordinator reactivated the same canonical task; its retry completed the packet.
No substitute collector was launched. The packet's unavailable PR/review detail
remains a limit; separate reviewer API access validated only public
cutoff-bounded release, run, and one issue-timeline record.

## Key Findings

| Finding | Severity | Effort | Evidence links | Confidence and limitation | Consequence | Taxonomy |
|---|---|---|---|---|---|---|
| No approved evidence establishes Acme authority for prioritizing, accepting, promoting, deferring, stopping, rolling back, or granting exceptions for Healthchecks changes under any option. | High | M | [Evidence ledger](../../evidence/evidence-ledger.md), E-060; [open-items register](../../controls/open-items.md), OI-022; [change control](../../controls/project-health/release-change-control.md) | High confidence for the approved-source boundary; informal Acme practice may exist but was intentionally not examined. | A core monitoring change can bypass five-minute, recovery, security, capacity, or claim gates without an accountable decision. | none |
| Upstream green CI, tags, releases, and Docker publication are useful inputs but are not an Acme acceptance or promotion gate; required checks and release-to-test enforcement were not established. | High | M | [Evidence ledger](../../evidence/evidence-ledger.md), E-009, E-010, E-058; [open-items register](../../controls/open-items.md), OI-008 | Strong declarations and historical results; no Acme deployment or enforcement record. | Directly consuming a tag/image can promote a change without Acme job, human-alert, recovery, or rollback proof. | none |
| Upstream exposes a long-running issue/Git/changelog/release trail and one selected issue traces cleanly through feedback, fifteen commits, closure, and v4.3; traceability is not uniform. | Medium | S | [Evidence ledger](../../evidence/evidence-ledger.md), E-057 and E-059 | One selected sample; v4.3 cites issues for 4 of 16 listed changes, so neither sample nor count proves project-wide practice. | Acme can reuse upstream provenance for triage, but missing links require its own bounded diff and acceptance record. | none |
| Make adds fork priority, design, review, merge, security response, artifact publication, documentation, release, and successor authority without an evidenced source need or Acme governance. | High | L | [Evidence ledger](../../evidence/evidence-ledger.md), E-049 and E-060; [open-items register](../../controls/open-items.md), OI-017 | High confidence in responsibility delta; Acme skill and capacity remain unknown. | Fork stewardship can divert 36-month feature opportunity time and create an unreviewed release dependency. | none |
| Buy reduces Acme source/runtime release work but still needs accountable acceptance of vendor, data, identity, contract, integration, quota, alert, and exit changes. | High | M | [Evidence ledger](../../evidence/evidence-ledger.md), E-060; [change control](../../controls/project-health/release-change-control.md); [open-items register](../../controls/open-items.md), OI-004 | Process allocation is evidence-bounded; hosted internals and negotiated change commitments are unavailable. | Treating purchase as acceptance can silently invalidate Acme's five-minute or security boundary after a service change. | none |
| No approved evidence establishes a closure-to-learning link from completed/deferred changes, incidents, or failed controls to verified updates. | Medium | M | [Evidence ledger](../../evidence/evidence-ledger.md), E-059 and E-060; [open-items register](../../controls/open-items.md), OI-023 | High confidence for approved sources; no inference about informal practice. OI-019 separately owns triggers, cadence, and retention. | A decided or observed problem can recur without updating tests, runbooks, controls, or claims. | none |
| Contributor, changelog, README, and Docker material serves upstream contributors, users, and self-hosting operators, but only partially covers production release, rollback, authority, and learning tasks. | Medium | S | [Evidence ledger](../../evidence/evidence-ledger.md), E-056 and E-059; [documentation catalog](../../documentation/catalog.md) | Source documents were current in the pinned tree; most lack explicit update dates and are not Acme procedures. | A small team following upstream documentation alone can perform mechanics without a complete production decision record. | none |

## Mandate-Relevant Strengths

- The pinned commit had 22,750 successful hosted test executions, strict mypy,
  and three completed CodeQL jobs, giving Acme strong upstream regression input
  without claiming production acceptance ([evidence ledger](../../evidence/evidence-ledger.md), E-010).
- Public Git history spans 3,913 commits, the repository has 77 version tags,
  and the changelog separates released versions from current development. This
  makes upstream change review materially more tractable than an opaque source
  dependency ([evidence ledger](../../evidence/evidence-ledger.md), E-041 and E-059).
- Upstream states issue-first expectations for larger work and tests for fixes
  and features; the selected issue demonstrates one functioning feedback and
  release trace ([evidence ledger](../../evidence/evidence-ledger.md), E-056 and E-057).
- The release workflow requests a multi-architecture build and SBOM, and the
  latest cutoff release-triggered run succeeded. Acme can treat this as
  provenance input while separately enforcing immutable promotion
  ([evidence ledger](../../evidence/evidence-ledger.md), E-058).

### Decision Insights

1. **Prefer pull to make on delivery-process evidence.** Pull can consume a
   mature upstream history, test suite, changelog, and release path while Acme
   owns only selection and production acceptance. Make retains every pull gate
   and adds a permanent release organization. Choosing make before a measured
   source need and OI-017 charter would spend feature opportunity time while
   increasing the chance of an unreviewed fork release. Keep make stopped.
2. **Do not let the buy case bypass change control.** Buy removes Acme's source
   publication step, not its acceptance decision. Vendor, plan, data, identity,
   notification, integration, and exit changes can still invalidate the
   operating contract. Close OI-004 and OI-022 with a hosted-service change
   record before treating buy as lower-risk.
3. **Close authority before measuring cadence.** OI-018/OI-019 can measure and
   schedule maintenance only after a named authority decides what enters,
   passes, defers, or rolls back. Otherwise elapsed effort and green checks do
   not show that risk-bearing work is accepted. Implement OI-022 first, then
   use OI-023 to learn from the resulting record.

## Selected Outputs

- Required delivery/process assessment: this report.
- Triggered integrated work-in-flight, operating-cadence, release/change-control,
  and learning view: [release-change-control.md](../../controls/project-health/release-change-control.md).
- Requested shared evidence: [github-history-and-hosted-ci.md](../../evidence/packets/github-history-and-hosted-ci.md).
- No separate `delivery-and-quality` packet was requested: current declarations,
  hosted executions, executable-check boundaries, and Acme gate gaps were
  already registered in E-009 through E-013 and the Code Quality control; a new
  packet would duplicate rather than close a material process question.

## Material Omissions, Unknowns, And Auditor Questions

No Acme delivery records, issue tracker, change calendar, release authority,
deputy, deployment history, emergency route, incident review, or vendor-change
notice was approved. Team capability remains intentionally unknown. Public
evidence does not establish universal upstream review, approval, release
separation, predictable support/cadence, or hosted change governance. These are
preserved through OI-002, OI-004, OI-008, OI-016..OI-019, and OI-022..OI-023.

No auditor question is raised. The missing proof and authority have actionable
closure routes and do not change the remaining audit scope.

This reviewer started no project tests because its question is delivery/process
evidence and existing registered execution results were reused. Project Health
test totals are therefore 0 passed, 0 failed, 0 errors, and 0 skipped.

## Reconciliation

Code Quality's green upstream checks and unproven enforcement are consistent
with this review. Maintenance Cost's recurring release demand, Revenue Risk's
claim stop conditions, and Contributor/Vendor Value's concentrated authority
all strengthen the need for an Acme-owned gate without proving team readiness.
The current PR template and `CONTRIBUTING.md` issue-comment route conflict as
workflow instructions; Contributor/Vendor Value owns participation impact,
while Project Health retains only the trace/review ambiguity.

The same `github-history-and-hosted-ci` collector start first ended `blocked`
without writes because its process environment could not start. A
coordinator-authorized retry under the same canonical task completed the packet;
each start has one terminal outcome and no child remains open. Direct reviewer
API access succeeded later and narrows the collector's access limit only for
the cutoff release/run and issue records registered in E-057/E-058.

One independent quality review returned `REVISE`. This single revision repaired
non-resolving register anchors, bounded authority wording to the approved source
set, and narrowed OI-023 to closure-to-learning linkage without duplicating
OI-019. Canonical structural validation after revision completed with 0 errors
and 0 warnings.

## Bounded Conclusion And Downstream Guidance

Upstream Healthchecks has useful, active delivery evidence: public history,
issue-based intake, a changelog, frequent version tags, broad green CI, and a
working release/image path. It does not provide Acme's priority, acceptance,
promotion, rollback, exception, or learning authority. Pull is the least
process-expansive self-host path but remains gated by OI-008/OI-022. Make is not
process-justified and remains stopped under OI-017. Buy reduces source/runtime
change work but still requires OI-004/OI-022 service-change acceptance.

Synthesis should use this process allocation and must not infer option approval,
team capability, live reliability, product correctness, or sustainable cadence.
